PharmaCircle Business Class Elite - from commercial insights to clinical trials
Jinfo Blog
28th September 2018
Abstract
How does PharmaCircle Business Class Elite (BCE) fare for those seeking information on companies in the biopharmaceutical space, with its global coverage of business, research, development, regulatory and formulation science? Get a feel for BCE in this blog about our latest review.
Item
PharmaCircle specialises in providing comprehensive product and business-related information to companies in the biopharmaceutical space.
Jinfo has published several product reviews over the past few years highlighting its portfolio of products, and our most recent "Product review of PharmaCircle Business Class Elite" (Subscription content) showcases this online platform. It offers continuously updated information on products and pipeline programmes, public and private companies, and global clinical trial records.
Used by clients including the top 20 pharmaceutical companies, it offers quick access to relevant, validated and updated content, with every record undergoing multiple rigorous quality check processes.
Extensive global coverage
Reviewer Ashish Shukla is an independent consultant to the biopharmaceutical industry with over six years of experience in market research and competitive intelligence. He holds an MSc in life sciences and a PhD in cancer biology.
He points out that the Business Class Elite product, "has been specially designed and developed for large corporations... and provides complete coverage in the US, the EU, and Japan and extensive coverage in Canada and other regions".
Find out more
PharmaCircle Business Class Elite (BCE) is used by pharma executives involved in diverse functions, like competitive intelligence, product strategy, pipeline and portfolio planning, medical affairs, business information management, regulatory affairs, and strategic initiatives.
Read the review to find out more about the platform's technology, value, key advantages, development plans and well-designed apps. If you have a Jinfo Subscription you can log in now to read the "Product review of PharmaCircle Business Class Elite".
If you don't have a Jinfo Subscription but would like to read this product review plus original research, expert articles, and attend our events, find out how to purchase your Subscription here.
- Blog post title: PharmaCircle Business Class Elite - from commercial insights to clinical trials
- Link to this page
- View printable version
- Mini review of AdisInsight - a "one-stop solution" for pharmaceutical researchers
Wednesday, 15th March 2017
- PharmaCircle Business Class Professional - global coverage for pharma business development
Thursday, 29th June 2017
- Product review of PharmaCircle Business Class Elite (BCE)
Thursday, 20th September 2018
Discussing news and AI strategies with the Financial Times
Community session
21st November 2024
2025 strategic planning; evaluating research reports; The Financial Times, news and AI
Blog posting
5th November 2024
November 2024 Update
YouTube video
7th November 2024
- 2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024 - All recent Jinfo Subscription content
31st October 2024 - End-user training best practice research
24th October 2024
- Jinfo Community session (TBC) (Community) 11th December 2024
- Discussing news and AI strategies with the Financial Times (Community) 21st November 2024
- Asia-Pacific Community session (Community) 19th November 2024